The Race toward Equity: Increasing Racial Diversity in Cancer Research and Cancer Care.

Cancer Discov

Department of Biochemistry and Molecular Biology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Published: October 2020

Cancer research and cancer care require deliberate attention to racial diversity. Here we comment on the ongoing issues of diversity and racism in cancer research.

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-20-1193DOI Listing

Publication Analysis

Top Keywords

racial diversity
8
cancer cancer
8
cancer care
8
cancer
5
race equity
4
equity increasing
4
increasing racial
4
diversity cancer
4
care cancer
4
care require
4

Similar Publications

Objectives: Racial discrimination is consistently linked to negative mental health outcomes. However, less is known about how unique patterns of coping in Black Americans experiencing high discrimination stress may moderate the association between discrimination and mental health. The present study uses person-centered methods to identify and describe latent profiles of coping in Black Americans, to understand how these coping profiles are linked to mental health, and to examine whether latent coping profiles moderate the links between discrimination and mental health.

View Article and Find Full Text PDF

Background: Recent advances in automatic face recognition have increased the risk that de-identified research imaging data could be re-identified from face imagery in brain scans.

Method: An ADNI committee of independent imaging experts evaluated 11 published techniques for face-deidentification ("de-facing") and selected four algorithms (FSL-UK Biobank, HCP/XNAT, mri_reface, and BIC) for formal testing using 183 longitudinal scans of 61 racially and ethnically diverse ADNI participants, evaluated by their facial feature removal on 3D rendered surfaces (confirming sufficient privacy protection) and by comparing measurements from ADNI routine image analyses on unmodified vs. de-faced images (confirming negligible side effects on analyses).

View Article and Find Full Text PDF

Background: Peak-width of skeletonized mean diffusivity (PSMD) is an emerging biomarker of cerebral small vessel disease (cSVD)-related vascular contributions to cognitive impairment and dementia (VCID). Higher PSMD values reflect greater white matter microstructural damage, and prior research has related PSMD to sporadic and monogenic forms of cSVD and worse cognitive function. Therefore, we proposed PSMD as a risk stratification biomarker for VCID.

View Article and Find Full Text PDF

Background: Tau pathology accumulates early in the basal forebrain (BF) in Alzheimer's disease (AD). The feasibility of measuring in vivo BF tau is unclear given PET resolution and possible partial volume effects of off-target signal (OTS) which varies by tracer.

Method: We compared measurements of tau in cognitively unimpaired older adults with either an FTP or MK6240 scan: 93 FTP scans from the Berkeley Aging Cohort Study (BACS), 424 FTP scans from ADNI (N=517 FTP scans; 72.

View Article and Find Full Text PDF

Background: Canada and the United States are both aging and becoming increasingly diverse. Despite this demographic shift, non-White racial/ethnic groups remain underrepresented in research on cognitive impairment and dementia. A major barrier to inclusivity is the lack of cognitive assessments that are valid in individuals with diverse language and cultural backgrounds.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!